Patents Examined by C. Delecroix-Muirheid
  • Alteration of circadian rhythmicity with a tachykinin antagonist
    Patent number: 6274604
    Abstract: A tachykinin antagonist is useful, alone or in conjunction with other agents, for altering circadian rhythmicity and alleviating circadian rhythm disorders and for enhancing and improving the quality of sleep.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: August 14, 2001
    Assignee: Merck & Co., Inc.
    Inventor: Carl Mendel